Paediatric patching not necessary

Article

Early unilateral cataract surgery in infants can produce good visual outcomes even if patching is discontinued, according to a study in the August 2008 issue of the Archives of Ophthalmology.

Early unilateral cataract surgery in infants can produce good visual outcomes even if patching is discontinued, according to a study in the August 2008 issue of the Archives of Ophthalmology.

Scott R. Lambert, MD of Emory Eye Center, Atlanta, US and colleagues conducted a medical record review of paediatric subjects (n=9) who had undergone surgery to treat unilateral congenital cataract at a mean age of 21.7 days. Subjects had remained patched for a mean 6.7 hours/day until at least 12 months of age, after which patching compliance declined to a mean of 1.7 hours/day by six years of age.

Four children abandoned patching entirely before their sixth birthdays: three maintained or increased visual acuity, whereas the fourth child lost two lines.

The researchers concluded that, if patients comply with the prescribed patching regime in early childhood, visual acuity can be maintained if patching is discontinued before the patient reaches six years of age.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.